These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10362395)

  • 21. Selective inducible nitric oxide synthase inhibition in septic shock.
    Beilman GJ
    Crit Care Med; 2001 Nov; 29(11):2230-1. PubMed ID: 11700433
    [No Abstract]   [Full Text] [Related]  

  • 22. Regional intestinal blood flow and nitric oxide synthase inhibition during sepsis in the rat.
    Klemm K; Moody FG
    Ann Surg; 1998 Jan; 227(1):126-33. PubMed ID: 9445120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Septic shock and NO].
    Mitaka C
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():540-3. PubMed ID: 15506445
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of glucocorticoid receptor binding by nitric oxide in endotoxemic rats.
    Duma D; Silva-Santos JE; Assreuy J
    Crit Care Med; 2004 Nov; 32(11):2304-10. PubMed ID: 15640646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis and innovative treatment of septic shock.
    Ognibene FP
    Adv Intern Med; 1997; 42():313-38. PubMed ID: 9048123
    [No Abstract]   [Full Text] [Related]  

  • 26. Nitric oxide inhibition in the treatment of septic shock.
    Bone HG; Traber DL
    Crit Care Med; 1996 Aug; 24(8):1422-3. PubMed ID: 8706502
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of nitric oxide synthase inhibitors on the changes of hemodynamic parameters and aortic tension induced by septic shock in rats].
    Xia ML; Zhou XM; Xu C; Qian LB; Xia Q
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Aug; 24(3):279-84. PubMed ID: 21141582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress.
    Virdis A; Colucci R; Fornai M; Blandizzi C; Duranti E; Pinto S; Bernardini N; Segnani C; Antonioli L; Taddei S; Salvetti A; Del Tacca M
    J Pharmacol Exp Ther; 2005 Mar; 312(3):945-53. PubMed ID: 15547110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The timing of endothelin and nitric oxide inhibition affects survival in a mice model of septic shock.
    Iskit AB; Guc MO
    Eur J Pharmacol; 2001 Mar; 414(2-3):281-7. PubMed ID: 11239929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock.
    Petros A; Bennett D; Vallance P
    Lancet; 1991 Dec 21-28; 338(8782-8783):1557-8. PubMed ID: 1720856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of septic shock in rats with nitric oxide synthase inhibitors and inhaled nitric oxide.
    Pedoto A; Tassiopoulos AK; Oler A; McGraw DJ; Hoffmann SP; Camporesi EM; Hakim TS
    Crit Care Med; 1998 Dec; 26(12):2021-8. PubMed ID: 9875915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Bakker J; Grover R; McLuckie A; Holzapfel L; Andersson J; Lodato R; Watson D; Grossman S; Donaldson J; Takala J;
    Crit Care Med; 2004 Jan; 32(1):1-12. PubMed ID: 14707554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nitric oxide--an important mediator in sepsis?].
    Kirkebøen KA; Strand OA
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4061-5. PubMed ID: 10613098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Septic shock and nitric oxide].
    Lorente JA; Delgado MA; Landín L
    Enferm Infecc Microbiol Clin; 1997 Oct; 15 Suppl 3():14-9. PubMed ID: 9410077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of endothelin and nitric oxide on organ injury, mesenteric ischemia, and survival in experimental models of septic shock.
    Iskit AB; Guc O
    Acta Pharmacol Sin; 2003 Oct; 24(10):953-7. PubMed ID: 14531935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide: moving towards the clinic.
    Kilbourn RG
    Mol Med Today; 1996 Aug; 2(8):324. PubMed ID: 8796916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide inhibition in the treatment of septic shock.
    Hata JS; Dellinger RP
    Crit Care Med; 1995 Oct; 23(10):1621-4. PubMed ID: 7587224
    [No Abstract]   [Full Text] [Related]  

  • 38. Methylene blue: NO panacea.
    Schreiber MD
    J Pediatr; 1996 Dec; 129(6):790-3. PubMed ID: 8969718
    [No Abstract]   [Full Text] [Related]  

  • 39. NO-synthase inhibition in sepsis.
    Spiel AO; Mayr FB
    Thromb Haemost; 2006 Apr; 95(4):591-2. PubMed ID: 16601826
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of the nitric oxide inhibitor, L-N(G)-monomethylarginine, on accumulation of interleukin-6 and interleukin-8, and nuclear factor-kappaB activity in a human endothelial cell line.
    Galley HF; Nelson SJ; Dhillon J; Dubbels AM; Webster NR
    Crit Care Med; 1999 May; 27(5):908-12. PubMed ID: 10362412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.